Quick Answer
EXAGEN INC. reported R&D Expense of $6.25 million for fiscal year 2025.
EXAGEN INC. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $6.25M | +16.4% |
| 2024 | $5.38M | +10.5% |
| 2023 | $4.87M | -50.7% |
| 2022 | $9.88M | +36.5% |
| 2021 | $7.24M | +102.8% |
| 2020 | $3.57M | +64.0% |
| 2019 | $2.18M | +2.4% |
| 2018 | $2.12M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.73M | +16.8% | +16.7% |
| June 30, 2025 | $1.48M | +25.8% | +15.5% |
| March 31, 2025 | $1.28M | +21.2% | -13.3% |
| September 30, 2024 | $1.48M | +5.8% | +25.6% |
| June 30, 2024 | $1.18M | -6.7% | +11.3% |
| March 31, 2024 | $1.06M | -6.0% | -24.4% |
| September 30, 2023 | $1.40M | -41.2% | +10.8% |
| June 30, 2023 | $1.26M | -53.0% | +12.2% |
- EXAGEN INC. showed an increase of +16.4% in R&D Expense compared to the prior fiscal year.
- Over the 2018–2025 period, EXAGEN INC.’s r&d expense has grown by 194.3% (from $2.12 million to $6.25 million).
- The most recent figure is from EXAGEN INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: